Liyi Li

机构：Nanjing University of Chinese Medicine, Chongqing Cancer Hospital · ORCID：0000-0003-0809-6388

发表论文 55 篇 · 总被引 1725 次 · h-index 18

代表论文

• Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer (2020 · Cell Death and Disease · 被引 49)
• Nrf2-miR-129-3p-mTOR Axis Controls an miRNA Regulatory Network Involved in HDACi-Induced Autophagy (2019 · Molecular Therapy · 被引 47)
• Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer (2023 · Cancer Immunology Immunotherapy · 被引 35)
• PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by Down-regulating MMP9 Expression through the ERK/p65 Pathway (2023 · Current Molecular Pharmacology · 被引 31)
• RKI‐1447 suppresses colorectal carcinoma cell growth via disrupting cellular bioenergetics and mitochondrial dynamics (2019 · Journal of Cellular Physiology · 被引 20)
• Controlling Nutritional Status (CONUT) Score Is A Predictor Of Post-Operative Outcomes In Elderly Gastric Cancer Patients Undergoing Curative Gastrectomy: A Prospective Study (2019 · Cancer Management and Research · 被引 18)